Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study
Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study. // American Heart Journal. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326002681?dgcid=rss_sd_all
Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study. American Heart Journal. https://www.sciencedirect.com/science/article/pii/S0002870326002681?dgcid=rss_sd_all
“Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study.” American Heart Journal.
@article{article34110,
title = {Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study},
journal = {American Heart Journal},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326002681?dgcid=rss_sd_all}
}